Alliance Pharma Plc (APH) Ordinary 1p

Sell:60.80pBuy:61.40p0.20p (0.33%)

FTSE AIM 100:0.42%
Market closed | Prices delayed by at least 15 minutes
Sell:60.80p
Buy:61.40p
Change:0.20p (0.33%)
Market closed | Prices delayed by at least 15 minutes
Sell:60.80p
Buy:61.40p
Change:0.20p (0.33%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Alliance Pharma plc is a United Kingdom-based international consumer healthcare company. The principal activity of the Company is to act as a holding company. The principal activity of the Company is the acquisition, marketing and distribution of consumer healthcare and pharmaceutical products. Its segments include Consumer Healthcare brands and Prescription Medicines. Its Consumer Healthcare brands include the Kelo-Cote franchise, Amberen, Nizoral, MacuShield, Aloclair, Vamousse, and other consumer healthcare brands. Its Prescription Medicines include Hydromol, Flamma Franchise, Forceval and other prescription medicines. Its products include Aloclair Plus Gel, Aloclair Plus Spray, Aloclair Plus Mouthwash, Anbesol Adult Strength Gel, Anbesol Teething Gel, Anbesol Liquid, Atopiclair Cream, and Atopiclair Lotion. It holds marketing rights to around 80 consumer healthcare brands and prescription medicines, which are sold worldwide in more than 100 countries.

Key people

Nick Sedgwick
Chief Executive Officer, Executive Director
Andrew Franklin
Chief Financial Officer, Executive Director
Chris Chrysanthou
Group General Counsel, Company Secretary
Camillo Pane
Non-Executive Chairman of the Board
Peter Butterfield
Non-Executive Independent Director
Richard Crispin Morgan Jones
Senior Non-Executive Independent Director
Richard Mckenzie
Non-Executive Independent Director
Kristof Neirynck
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    APH
  • Location
    United Kingdom
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    GB0031030819
  • Market cap
    £328.66m
  • Employees
    290
  • Shares in issue
    540.57m
  • Exchange
    London Stock Exchange (LON)
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.